ranitidine has been researched along with Brain Vascular Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamsai, M; Niyomthai, N; Ovartlarnporn, B; Prichaworawach, S; Tansakool, U; Wuthi, S | 1 |
| Bauer, M; Eicher, H; Platt, D | 1 |
| Mathier, VH; Pérez, HR; Soria, F | 1 |
1 trial(s) available for ranitidine and Brain Vascular Disorders
| Article | Year |
|---|---|
The magnitude of nocturnal acid suppression by ranitidine 300 mg given at 18.00 hours.
Topics: Aged; Cerebrovascular Disorders; Circadian Rhythm; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Peptic Ulcer; Ranitidine; Stress, Physiological | 1992 |
2 other study(ies) available for ranitidine and Brain Vascular Disorders
| Article | Year |
|---|---|
Pharmacokinetics of ranitidine in geriatric patients with multiple diseases.
Topics: Aged; Aged, 80 and over; Aging; Cerebrovascular Disorders; Coronary Disease; Creatinine; Diabetes Complications; Diabetes Mellitus; Female; Humans; Infusions, Intravenous; Male; Peptic Ulcer; Ranitidine; Stress, Physiological | 1989 |
[Incidence of acute gastroduodenal lesions in patients with intracranial lesions. Prophylactic value of treatment with ranitidine].
Topics: Cerebrovascular Disorders; Drug Evaluation; Gastric Acid; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Random Allocation; Ranitidine; Risk; Stress, Physiological | 1985 |